Immune Checkpoint Inhibitor–Induced Type 1 Diabetes: An Underestimated Risk
Abstract
Drs Marin-Acevedo and colleagues nicely summarize the toxicities associated with immune checkpoint inhibitor therapy.1Marin-Acevedo J.A. Chirila R.M. Dronca R.S. Immune checkpoint inhibitor toxicities.Mayo Clin Proc. 2019; 94: 1321-1329Abstract Full Text Full Text PDF PubMed Scopus (46) Google Scholar We want to further emphasize immune checkpoint inhibitor–induced type 1 diabetes (ICI-T1D), as it frequently presents with life-threatening...
Paper Details
Title
Immune Checkpoint Inhibitor–Induced Type 1 Diabetes: An Underestimated Risk
Published Date
Mar 1, 2020
Journal
Volume
95
Issue
3
Pages
614 - 615
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History